PLXS · Plexus Corp · Insider Trading

Shares were sold pursuant to a Rule 10b5-1 plan adopted on November 20, 2025.

Each Restricted Stock Unit granted under the Plexus Corp. 2024 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represented a contingent right to receive one share of Plexus Corp. common stock. One third of the Restricted Stock Units vested and settled on September 15, 2026.

Each Restricted Stock Unit granted under the Plexus Corp. 2024 Omnibus Incentive Plan, which qualifies under Rule 16b-3, represented a contingent right to receive one share of Plexus Corp. common stock. One third of the Restricted Stock Units vested and settled on September 15, 2026.

Shares were sold pursuant to a Rule 10b5-1 plan adopted on February 6, 2026.

Shares were sold pursuant to a Rule 10b5-1 plan adopted on November 20, 2025.

This transaction was executed in multiple trades at prices ranging from $251.00 to $251.18 per share. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Shares were sold pursuant to a Rule 10b5-1 plan adopted on November 20, 2025.

Shares were sold pursuant to a Rule 10b5-1 plan adopted on November 20, 2025.

Shares were sold pursuant to a Rule 10b5-1 plan adopted on May 8, 2026.

Shares were sold pursuant to a Rule 10b5-1 plan adopted on November 20, 2025.

Shares were sold pursuant to a Rule 10b5-1 plan adopted on November 20, 2025.

This transaction was executed in multiple trades at prices ranging from $261.00 to $261.68 per share. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Shares were sold pursuant to a Rule 10b5-1 plan adopted on November 20, 2025.

This transaction was executed in multiple trades at prices ranging from $296.01 to $296.23 per share. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Shares were sold pursuant to a Rule 10b5-1 plan adopted on November 20, 2025.

Shares were sold pursuant to a Rule 10b5-1 plan adopted on November 20, 2025.

This transaction was executed in multiple trades at prices ranging from $295.045 to $295.81 per share. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Shares were sold pursuant to a Rule 10b5-1 plan adopted on November 20, 2025.

This transaction was executed in multiple trades at prices ranging from $294.1875 to $294.19 per share. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Shares were sold pursuant to a Rule 10b5-1 plan adopted on February 2, 2026.

Shares were sold pursuant to a Rule 10b5-1 plan adopted on November 20, 2025.

This transaction was executed in multiple trades at prices ranging from $253.00 to $253.40 per share. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Shares were sold pursuant to a Rule 10b5-1 plan adopted on November 20, 2025.

This transaction was executed in multiple trades at prices ranging from $251.9508 to $252.5301 per share. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

This transaction was executed in multiple trades at prices ranging from $271.00 to $271.50 per share. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

This transaction was executed in multiple trades at prices ranging from $263.825 to $264.63 per share. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

This transaction was executed in multiple trades at prices ranging from $265.97 to $266.20 per share. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

This transaction was executed in multiple trades at prices ranging from $264.88 to $265.815 per share. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

This transaction was executed in multiple trades at prices ranging from $263.24 to $263.855 per share. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

This transaction was executed in multiple trades at prices ranging from $262.00 to $262.94 per share. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

This transaction was executed in multiple trades at prices ranging from $264.04 to $264.49 per share. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Shares of Plexus Corp. common stock formerly held in the Plexus Corp. 401(k) Savings Plan.

Shares were sold pursuant to a Rule 10b5-1 plan adopted on November 20, 2025.

This transaction was executed in multiple trades at prices ranging from $223.98 to $224.30 per share. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Shares were sold pursuant to a Rule 10b5-1 plan adopted on November 20, 2025.

Shares were sold pursuant to a Rule 10b5-1 plan adopted on February 28, 2024.

This transaction was executed in multiple trades at prices ranging from $201.40 to $201.41 per share. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Shares were sold pursuant to a Rule 10b5-1 plan adopted on November 20, 2025.

This transaction was executed in multiple trades at prices ranging from $196.10 to $196.65 per share. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Shares were sold pursuant to a Rule 10b5-1 plan adopted on November 20, 2025.

This transaction was executed in multiple trades at prices ranging from $194.075 to $194.90 per share. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Shares were sold pursuant to a Rule 10b5-1 plan adopted on November 20, 2025.

This transaction was executed in multiple trades at prices ranging from $195.00 to $195.96 per share. The reported price reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Based on Company performance during the three-year performance period, 142.4% of the portion of the Performance Stock Units ("PSUs") granted in fiscal 2023 related to the relative total shareholder return ("TSR") of the Company's common stock as compared to companies in the S&P 400 Index vested. As previously disclosed, the reporting person had the opportunity to earn up to 150% of the targeted amount of PSUs based on TSR originally reported.

Based on Company performance during the three-year performance period, 142.4% of the portion of the Performance Stock Units ("PSUs") granted in fiscal 2023 related to the relative total shareholder return ("TSR") of the Company's common stock as compared to companies in the S&P 400 Index vested. As previously disclosed, the reporting person had the opportunity to earn up to 150% of the targeted amount of PSUs based on TSR originally reported.

Based on Company performance during the three-year performance period, 142.4% of the portion of the Performance Stock Units ("PSUs") granted in fiscal 2023 related to the relative total shareholder return ("TSR") of the Company's common stock as compared to companies in the S&P 400 Index vested. As previously disclosed, the reporting person had the opportunity to earn up to 150% of the targeted amount of PSUs based on TSR originally reported.

Based on Company performance during the three-year performance period, 142.4% of the portion of the Performance Stock Units ("PSUs") granted in fiscal 2023 related to the relative total shareholder return ("TSR") of the Company's common stock as compared to companies in the S&P 400 Index vested. As previously disclosed, the reporting person had the opportunity to earn up to 150% of the targeted amount of PSUs based on TSR originally reported.